Hindcon Chemicals Bilan de santé

Santé financière contrôle des critères 6/6

Hindcon Chemicals possède un total de capitaux propres de ₹536.3M et une dette totale de ₹6.1M, ce qui porte son ratio d'endettement à 1.1%. Son actif total et son passif total sont ₹639.3M et de ₹103.0M. L'EBIT de Hindcon Chemicals est ₹43.4M ce qui fait que son ratio de couverture des intérêts -3.1. Elle dispose de liquidités et de placements à court terme de ₹104.9M.

Informations clés

1.1%

Ratio d'endettement

₹6.07m

Dette

Ratio de couverture des intérêts	-3.1x
Argent liquide	₹104.88m
Fonds propres	₹536.33m
Total du passif	₹103.02m
Total des actifs	₹639.35m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

There's Reason For Concern Over Hindcon Chemicals Limited's (NSE:HINDCON) Price

Nov 02

Shareholders May Be More Conservative With Hindcon Chemicals Limited's (NSE:HINDCON) CEO Compensation For Now

Aug 14

Risks Still Elevated At These Prices As Hindcon Chemicals Limited (NSE:HINDCON) Shares Dive 26%

Mar 21

With EPS Growth And More, Hindcon Chemicals (NSE:HINDCON) Makes An Interesting Case

Feb 15

What Hindcon Chemicals Limited's (NSE:HINDCON) 31% Share Price Gain Is Not Telling You

Dec 19

Should Hindcon Chemicals Limited (NSE:HINDCON) Be Part Of Your Dividend Portfolio?

Jan 16

Whole Time Director Nilima Goenka Just Bought 1.1% More Shares In Hindcon Chemicals Limited (NSE:HINDCON)

Dec 21

Trade Alert: The MD & Director Of Hindcon Chemicals Limited (NSE:HINDCON), Sanjay Goenka, Has Just Spent ₹209k Buying A Few More Shares

Dec 07

Read This Before Selling Hindcon Chemicals Limited (NSE:HINDCON) Shares

Nov 19

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de HINDCON ( ₹448.4M ) dépassent ses passifs à court terme ( ₹100.1M ).

Passif à long terme: Les actifs à court terme de HINDCON ( ₹448.4M ) dépassent ses passifs à long terme ( ₹2.9M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: HINDCON dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de HINDCON a été réduit de 1.5% à 1.1% au cours des 5 dernières années.

Couverture de la dette: La dette de HINDCON est bien couverte par le flux de trésorerie opérationnel ( 943.4% ).

Couverture des intérêts: HINDCON gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Hindcon Chemicals Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

There's Reason For Concern Over Hindcon Chemicals Limited's (NSE:HINDCON) Price

Investor sentiment improves as stock rises 20%

Shareholders May Be More Conservative With Hindcon Chemicals Limited's (NSE:HINDCON) CEO Compensation For Now

First quarter 2025 earnings released: EPS: ₹0.34 (vs ₹0.66 in 1Q 2024)

Upcoming dividend of ₹0.10 per share

New minor risk - Shareholder dilution

Hindcon Chemicals Limited, Annual General Meeting, Aug 20, 2024

Chairman & MD recently bought ₹2.0m worth of stock

Now 21% overvalued

Insufficient new directors

Investor sentiment improves as stock rises 16%

Now 20% overvalued

Investor sentiment improves as stock rises 15%

Risks Still Elevated At These Prices As Hindcon Chemicals Limited (NSE:HINDCON) Shares Dive 26%

Investor sentiment improves as stock rises 21%

With EPS Growth And More, Hindcon Chemicals (NSE:HINDCON) Makes An Interesting Case

Now 19% overvalued after recent price rise

Third quarter 2024 earnings released: EPS: ₹0.26 (vs ₹0.37 in 3Q 2023)

Investor sentiment improves as stock rises 35%

What Hindcon Chemicals Limited's (NSE:HINDCON) 31% Share Price Gain Is Not Telling You

Is Now The Time To Put Hindcon Chemicals (NSE:HINDCON) On Your Watchlist?

Whole Time Director recently bought ₹2.0m worth of stock

First quarter 2024 earnings released: EPS: ₹3.32 (vs ₹1.35 in 1Q 2023)

Hindcon Chemicals Limited to Report Q1, 2024 Results on Aug 12, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2023

Investor sentiment improves as stock rises 15%

Whole Time Director recently bought ₹63k worth of stock

Third quarter 2023 earnings released: EPS: ₹1.84 (vs ₹1.39 in 3Q 2022)

Chairman & MD recently bought ₹263k worth of stock

Second quarter 2023 earnings released: EPS: ₹0.71 (vs ₹0.97 in 2Q 2022)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₹0.70 per share

Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2022

Investor sentiment deteriorated over the past week

Full year 2022 earnings released

Insufficient new directors

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹0.97 (vs ₹1.48 in 2Q 2021)

First quarter 2021 earnings released: EPS ₹1.47 (vs ₹0.72 in 1Q 2020)

Upcoming dividend of ₹2.50 per share

Hindcon Chemicals (NSE:HINDCON) Is Increasing Its Dividend To ₹1.50

Investor sentiment improved over the past week

Whole Time Director recently bought ₹743k worth of stock

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Is Hindcon Chemicals Limited (NSE:HINDCON) An Attractive Dividend Stock?

Investor sentiment deteriorated over the past week

Estimating The Fair Value Of Hindcon Chemicals Limited (NSE:HINDCON)

New 90-day low: ₹24.00

MD & Director recently bought ₹100k worth of stock

Should Hindcon Chemicals Limited (NSE:HINDCON) Be Part Of Your Dividend Portfolio?

MD & Director recently bought ₹201k worth of stock

MD & Director recently bought ₹305k worth of stock

Whole Time Director Nilima Goenka Just Bought 1.1% More Shares In Hindcon Chemicals Limited (NSE:HINDCON)

Trade Alert: The MD & Director Of Hindcon Chemicals Limited (NSE:HINDCON), Sanjay Goenka, Has Just Spent ₹209k Buying A Few More Shares

MD & Director recently bought ₹209k worth of stock

Read This Before Selling Hindcon Chemicals Limited (NSE:HINDCON) Shares

Market bids up stock over the past week

New 90-day high: ₹19.70

Whole Time Director recently bought ₹660k worth of stock

Upcoming Dividend of ₹0.90 Per Share

Hindcon Chemicals Limited to Report First Half, 2020 Results on Jun 25, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines